BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 17600122)

  • 21. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
    Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
    Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.
    Hua H; Zhao QQ; Kalagbor MN; Yu GZ; Liu M; Bian ZR; Zhang BB; Yu Q; Xu YH; Tang RX; Zheng KY; Yan C
    World J Gastroenterol; 2024 Feb; 30(5):471-484. PubMed ID: 38414587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
    Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
    Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biliary HCO(3)(-) umbrella: experimental evidence revisited.
    Beuers U; Maroni L; Elferink RO
    Curr Opin Gastroenterol; 2012 May; 28(3):253-7. PubMed ID: 22450897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
    Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
    J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models of biliary injury and altered bile acid metabolism.
    Mariotti V; Strazzabosco M; Fabris L; Calvisi DF
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1254-1261. PubMed ID: 28709963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice.
    Hintermann E; Bayer M; Conti CB; Fuchs S; Fausther M; Leung PS; Aurrand-Lions M; Taubert R; Pfeilschifter JM; Friedrich-Rust M; Schuppan D; Dranoff JA; Gershwin ME; Manns MP; Imhof BA; Christen U
    J Autoimmun; 2018 Jul; 91():83-96. PubMed ID: 29753567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
    Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
    J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
    Baghdasaryan A; Claudel T; Kosters A; Gumhold J; Silbert D; Thüringer A; Leski K; Fickert P; Karpen SJ; Trauner M
    Gut; 2010 Apr; 59(4):521-30. PubMed ID: 20332524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease.
    Preisegger KH; Factor VM; Fuchsbichler A; Stumptner C; Denk H; Thorgeirsson SS
    Lab Invest; 1999 Feb; 79(2):103-9. PubMed ID: 10068199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
    Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
    Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
    Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
    J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pipe-3D: A Pipeline Based on Immunofluorescence, 3D Confocal Imaging, Reconstructions, and Morphometry for Biliary Network Analysis in Cholestasis.
    Damle-Vartak A; Begher-Tibbe B; Gunther G; Geisler F; Vartak N; Hengstler JG
    Methods Mol Biol; 2019; 1981():25-53. PubMed ID: 31016646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
    Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
    J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation.
    Omenetti A; Yang L; Li YX; McCall SJ; Jung Y; Sicklick JK; Huang J; Choi S; Suzuki A; Diehl AM
    Lab Invest; 2007 May; 87(5):499-514. PubMed ID: 17334411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
    Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.